Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Diverse Neoantigens and the Development of Cancer Therapies

Seminars in Radiation Oncology(2020)10.1016/j.semradonc.2019.12.001Source: DataRank Database

Diverse Neoantigens and the Development of Cancer Therapies is a research paper published in Seminars in Radiation Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

15 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.91)OA: closedTopics (28)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Tanaya A. Purohit,Timothy A. Chan ORCID,Raghvendra M. Srivastava ORCID

Live enrichment

PubMed:32381291 OpenAlex:https://openalex.org/W3022400151

National Cancer Institute

Grant: P30 CA008748

Pfizer

Grant: An2H

National Institutes of Health

Grant: R35 CA232097

National Institutes of Health

Grant: RO1 CA205426

NCI NIH HHS

Grant: R01 CA205426

Eisai

AstraZeneca

Bristol-Myers Squibb

FWCI

0.91

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1053429619300761?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1053429619300761?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.semradonc.2019.12.001

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32381291

Fields of Study

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy researchAntigens, NeoplasmCancer VaccinesCombined Modality TherapyHumansImmunotherapyNeoplasms

MeSH Terms

Antigens, NeoplasmCombined Modality TherapyHumansImmunotherapyNeoplasmsCancer Vaccines

Keywords

MedicineImmune systemAntigenImmunologyCancerCytotoxic T cellCD8Cancer immunotherapyImmunotherapyCancer researchBiologyGeneticsIn vitro

Sustainable Development Goals

SDG 0: Good health and well-being